Monday, 21 October 2019

Pharma News

  • Indian drug approval mechanism under fire

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2012

    On May 8, when Mr Brajesh Pathak, chairman of India's parliamentary standing committee on health and family welfare, presented its report on the way Central Drugs Standards Control Organiza...Read more

  • Iressa deaths: Japanese High Court rules in favor of AZ

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2012

    Singapore: The Japanese unit of AstraZeneca (AZ), has been acquitted, in a case that had held the firm responsible for the deaths of several individuals due to the side effects of the firm'...Read more

  • Sinopharm bullish on expansion

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

        Sinopharm Group continued to dominate the pharmaceutical industry in China and across the Asia Pacific region in 2011. With China's 12th Five Year Plan for pharmaceutical distribu...Read more

  • Prima recruits patients for cancer vaccine trial

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

    Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. Prima has authorized several centers in Ukraine to start enrolling pat...Read more

  • Merck pays Bionomics $172mn for pain molecules

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and Canada, to discover and develop novel small molecule candidates for ...Read more

  • Bayer initiates trial of new rFVIII to treat hemophilia A

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: Bayer HealthCare started enrolling patients in an international phase II/III trial called PROTECT VIII that is designed to evaluate its investigational compound BAY94-9027 for th...Read more

  • Alchemia demerges Audeo on NASDAQ, ASX

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

    Singapore: Alchemia has demerged its subsidiary, Audeo Oncology, on NASDAQ and the ASX. The company has announced that it has been unable to secure sufficient new investment for Audeo at te...Read more

  • Pfizer cancer drug gets first-ever China SFDA nod

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Feb, 2013

    Singapore: Pfizer received approval for Xalkori (crizotinib) for Chinese State Food and Drug Administration (SFDA), as the first-ever therapy for the treatment of patients with locally adva...Read more

  • Onyx rejects $10 bn takeover bid by Amgen

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

    Singapore: Onyx Pharmaceuticals rejected a $10 billion takeover offer from Amgen as too low but still is considering selling itself. Onyx said Amgen's cash offer of $120 a share significant...Read more

  • CSIR head: Indian bioscience education disappoints me

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 May, 2013

    In 2002, biotechnology was just in its nascent stage and was considered to be a small industry. However, the success story of the vaccine sector and the emergence of companies such as Bhara...Read more

  • Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand, to leverage and maximize the synergies of the Hybrid Business Model...Read more

  • ScinoPharm, Coland develop cancer generics in China

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 May, 2013

    ‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to develop a series of generic oncological drugs for China. Several Acti...Read more

  • Hoya appoints new executive officer

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2014

    Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and head of corporate development and affairs. As the company's first c...Read more

  • Ninad Deshpanday is Kemwell R&D president

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    Bangalore: India-based Kemwell Biopharma appointed Dr Ninad Deshpanday as president of R&D. Dr Deshpanday has over 22 years of experience in diverse international roles in the pharmaceu...Read more

  • China's Fosun strikes $534 mn deal with Swiss Sellas

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 25 Oct, 2013

    Singapore: In what could be a landmark deal, China's largest biotech company has struck a deal worth $534 million with Switzerland's specialty biopharmaceutical and clinical research giant,...Read more

  • Innovation in drug delivery system is in a constant state of evolution'

    Pharma |  Opinion | By Nandita Singh | 0 Comment | 14 Mar, 2012

    Ms Prasanna Vadhana Kannan is the industry analyst in medical devices & diagnostic imaging for Frost & Sullivan Asia Pacific. One of the notable advances transforming the field of ...Read more

  • Takeda's center among Chicago's top 100 workplaces

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2012

    Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago Tribune. The list of the best places to work in the Chicago area is ba...Read more

  • Eisai seeks nod for Helicobacter Pylori treatment

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare for approval of two types of new ...Read more



Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls